Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Metagenics, a California-based nutrigenomics and lifestyle medicine company, has made its dietary supplement that supports healthy aging of the brain CogniSure available with convenient once-a-day dosing.
Subscribe to our email newsletter
CogniSure is the sole US dietary supplement that has Colostrinin, the only colostrum-derived, protein-rich polypeptide (PRP) complex shown to influence brain aging mechanisms and to support adult cognitive function, Metagenics said.
CogniSure is exclusively licensed to Metagenics for distribution in North America, Australia, and New Zealand by ReGen Therapeutics, a London-based firm involved in research and distribution of this novel PRP complex.
Metagenics chief science officer Jeff Bland said that numerous cellular researches have demonstrated that Colostrinin may influence numerous activities associated with normal brain aging – including those related to genetic expression, antioxidant mechanisms, and immune function.
CogniSure is available exclusively through licensed health care providers that offer professional quality Metagenics products in convenient, chocolate-flavored chewable tablets which contain a daily dose of 100 mcg of Colostrinin in each.